The window of therapeutic opportunity in multiple sclerosis
Top Cited Papers
- 27 July 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 253 (1), 98-108
- https://doi.org/10.1007/s00415-005-0934-5
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Case report Goodpasture's syndrome associated with multiple sclerosisActa Neurologica Scandinavica, 2009
- The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up studyJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosisThe Lancet, 1999
- Axonal Transection in the Lesions of Multiple SclerosisThe New England Journal of Medicine, 1998
- Sustained remission of severe resistant autoimmune neutropenia with Campath‐1HBritish Journal of Haematology, 1997
- Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodiesQJM: An International Journal of Medicine, 1996
- Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.British Journal of Ophthalmology, 1995
- Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in cultureNeuron, 1995
- CAMPATH‐1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpuraBritish Journal of Haematology, 1993
- Analysis of serial measurements in medical research.BMJ, 1990